Harpreet S. Dhaliwal - Dec 30, 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PCVX	Stock Option (right to buy)	Award	$0	+15K		$0.00	15K	Dec 30, 2022	Common Stock	15K	$47.95	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Harpreet S. Dhaliwal is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Id	Content
F1	1/48 of shares subject to the option vest on January 30, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.